Noradrenergic Mechanisms in Parkinson's DiseaseCRC Press, 16 dic 1993 - 288 páginas Noradrenergic Mechanisms in Parkinson's Disease examines fundamental and clinical evidence explaining the progression of the disease. Featuring contributions from acknowledged international experts in the field, this book defines ideopathic Parkinson's disease and covers such topics as the alterations in Parkinson's disease, norepinephrine-dopamine interactions, noradrenergic control of striatal dopamine release, glial cells as targets of the central noradrenergic systems, and a theory regarding noradrenergic mechanisms in Parkinson's disease. New directions for research on Parkinson's disease are also explored. |
Índice
Defining idiopathic Parkinsons disease J M Gybels 1 | 12 |
Centre de Recherche Pierre Fabre Collège de France | 17 |
Recovery from MPTPinduced parkinsonian manifestations | 31 |
The possible role of noradrenergic deficits in selected signs | 59 |
The locus coeruleus in Parkinsons disease R RaismanVozari | 89 |
Interactions between noradrenaline and dopamine | 107 |
one step beyond | 127 |
Noradrenergic control of striatal dopamine release M Marien | 139 |
The effects of αadrenoceptor antagonists on extracellular | 159 |
Glial cells as targets of the central noradrenergic system | 173 |
Noradrenergic control of gap junction permeability in cultured | 205 |
a theory | 224 |
| 255 | |
Términos y frases comunes
6-OHDA lesions activity adenylate cyclase adrenergic adrenoceptors Agid agonists amphetamine animals antagonists Antelman arachidonic acid astrocytes basal behavior bilateral binding Biochem Brain Res catecholamine caudate nucleus cell loss central cerebral cortex clinical Colpaert cortical dopamine decrease degeneration dementia dopamine loss dopamine release dopaminergic dopaminergic neurons effect fibers Figure function gap junctions glia glial cells Glowinski glutamate haloperidol Hornykiewicz and Kish hypothalamus idazoxan idiopathic Parkinson's disease induced injection interactions Javoy-Agid junctional permeability Langston Lategan levels locomotor locus coeruleus locus coeruleus lesions Mavridis mg/kg microdialysis modulation motor MPTP MPTP primate MPTP-induced MPTP-treated Neurochem Neurology neurons Neurosci neurotransmitter nigrostriatal noradrenaline noradrenergic noradrenergic innervation noradrenergic system norepinephrine ns ns nucleus accumbens observed parkinsonian patients pathway Pharmacol pharmacological Pifl prefrontal cortex primate model putamen rat brain regions role Scatton serotonin significant stimulation striatal astrocytes striatal dopamine striatum studies substantia nigra symptoms syndrome Tassin tremor tyrosine hydroxylase vivo